Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: Feb 21, 2025, 4:00 PM
2.000
+0.040 (2.04%)
After-hours: Feb 21, 2025, 4:47 PM EST
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $43.71 million as of February 21, 2025.
Market Cap
43.71M
Enterprise Value
-123.31M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $43.71M, a decrease of -87.72%. That is a compound annual growth rate of -90.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 44.60M | -31.03% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |